bupropion hydrochloride (68788-7992)

Drug Facts

Product Profile

Brand Name bupropion hydrochloride

Generic Name bupropion hydrochloride

Labeler preferred pharmaceuticals inc.

Dosage Form TABLET, EXTENDED RELEASE

Routes

ORAL

Active Ingredients

bupropion hydrochloride 300 mg/1

Manufacturer

Preferred Pharmaceuticals Inc.

Identifiers & Regulatory

Product NDC 68788-7992

Product ID 68788-7992_335318d4-0d96-42e7-a3be-a11702751b4d

Product Type HUMAN PRESCRIPTION DRUG

Marketing Category ANDA

Application Number ANDA210497

Listing Expiration 2026-12-31

Marketing Start 2021-08-06

Pharmacologic Class

Classes

aminoketone [epc] dopamine uptake inhibitors [moa] increased dopamine activity [pe] increased norepinephrine activity [pe] norepinephrine uptake inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 687887992

Hyphenated Format 68788-7992

Supplemental Identifiers

RxCUI

993557

UNII

ZG7E5POY8O

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name bupropion hydrochloride (source: ndc)

Generic Name bupropion hydrochloride (source: ndc)

Application Number ANDA210497 (source: ndc)

Routes

ORAL

source: ndc

Resolved Composition

Strengths

300 mg/1

source: ndc

Packaging

100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7992-1)
30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7992-3)
60 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7992-6)
120 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7992-8)
90 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7992-9)

source: ndc

Packages (5)

68788-7992-1 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7992-1) 68788-7992-3 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7992-3) 68788-7992-6 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7992-6) 68788-7992-8 120 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7992-8) 68788-7992-9 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7992-9)

Ingredients (1)

bupropion hydrochloride (300 mg/1)

Linked Drug Pages (1)

BUPROPION HYDROCHLORIDE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload

{"route": ["ORAL"], "spl_id": "335318d4-0d96-42e7-a3be-a11702751b4d", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993557"], "spl_set_id": ["5dec4414-5595-46c9-ada9-3fbe98152040"], "manufacturer_name": ["Preferred Pharmaceuticals Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7992-1)", "package_ndc": "68788-7992-1", "marketing_start_date": "20210806"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7992-3)", "package_ndc": "68788-7992-3", "marketing_start_date": "20210806"}, {"sample": false, "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7992-6)", "package_ndc": "68788-7992-6", "marketing_start_date": "20210806"}, {"sample": false, "description": "120 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7992-8)", "package_ndc": "68788-7992-8", "marketing_start_date": "20210806"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7992-9)", "package_ndc": "68788-7992-9", "marketing_start_date": "20210806"}], "brand_name": "BUPROPION HYDROCHLORIDE", "product_id": "68788-7992_335318d4-0d96-42e7-a3be-a11702751b4d", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "68788-7992", "generic_name": "BUPROPION HYDROCHLORIDE", "labeler_name": "Preferred Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BUPROPION HYDROCHLORIDE", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "300 mg/1"}], "application_number": "ANDA210497", "marketing_category": "ANDA", "marketing_start_date": "20210806", "listing_expiration_date": "20261231"}